Clinical Trial Recruitment for Neurodegenerative Disease

A biopharmaceutical company focused on developing and commercializing innovative therapies for people with debilitating diseases engaged Seeker Health to accelerate patient engagement for a clinical trial of an investigational medicine for a neurodegenerative disease. 


the challenge

1.     Accelerate clinical trial enrollment

2.     Provide potential participants a patient-friendly and direct way to learn about this clinical trial and sign up to participate

3.     Create a secure environment to share data with clinical trial staff to facilitate screening and enrollment into the clinical trial 


The approach

Seeker Health designed and implemented a compliant patient lead generation program centered around a targeted Facebook advertising campaign. To mitigate risk of user-generated misinformation, we deployed our tool for complete comment suppression.

Patients were directed to a clinical trial website that we designed and included a voluntary online pre-screener. All materials were available in English, French and Spanish and received IRB/EC approval prior to being used.

Authorized clinical trial personnel securely accessed data for patient screening and enrollment via our proprietary Seeker Portal.

The results

  • Seeker Health’s approach and process engaged a significant pool of potential participants who were pre-screened and then further screener

  • In five months, Seeker Health contributed 17 RANDOMIZED PATIENTS.



We would love to help your company get outstanding results in clinical trial enrollment. Learn more about our process here, and contact us today.